Updates in Drug-Related Pneumonitis Due to Targeted Oncologic Therapies

An increasing number of newer targeted oncologic therapies approved for clinical use can cause drug-related pneumonitis. Drug-related pneumonitis can be difficult to diagnose and requires a high index of suspicion. This review serves as an update to a prior review in this journal about pneumonitis w...

Full description

Bibliographic Details
Published in:	Journal of Immunotherapy and Precision Oncology
Main Authors:	Kathy L. Chan, Saadia A. Faiz, Mehmet Altan, Ajay Sheshadri
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2024-11-01
Subjects:	pneumonitis precision oncology pulmonary adverse event antibody-drug conjugate
Online Access:	https://jipo.org/doi/pdf/10.36401/JIPO-24-12

Similar Items

Pneumonitis After Precision Oncology Therapies: A Concise Review
by: Akash Jain, et al.
Published: (2018-07-01)

Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis
by: Kathryn A. Lai, et al.
Published: (2020-11-01)

Case report: Interstitial pneumonitis after initiation of lamotrigine
by: Victoria Watzal, et al.
Published: (2023-07-01)

A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity
by: Wang Chun Kwok, et al.
Published: (2022-04-01)

Pneumonitis and multiple pneumonial infections under combined immune‐checkpoint inhibition
by: Kristine E. Mayer, et al.
Published: (2023-06-01)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
by: Yuhei Kinehara, MD, PhD, et al.
Published: (2023-11-01)

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events
by: Mehmet Altan, et al.
Published: (2023-12-01)

Development and validation of a nomogram for predicting immune‐related pneumonitis after sintilimab treatment
by: Baohui Hong, et al.
Published: (2024-02-01)

Treatment dilemmas in patients with gastrointestinal stromal tumors (GIST) who experienced imatinib-induced pneumonitis: A case series
by: Deborah van de Wal, et al.
Published: (2024-03-01)

Antibody–Biopolymer Conjugates in Oncology: A Review
by: Vivek P. Chavda, et al.
Published: (2023-03-01)

Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis
by: Mohamed Abdelhakim Elnady, et al.
Published: (2023-02-01)

Early recognition of acute pneumonitis in amiodarone treatment
by: Rishi Vinod Lohiya, et al.
Published: (2018-01-01)

Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort
by: E Seixas, et al.
Published: (2022-12-01)

A Review of Practice-Changing Therapies in Oncology in the Era of Personalized Medicine
by: Mariana Pilon Capella, et al.
Published: (2024-04-01)

The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
by: Ke Ma, et al.
Published: (2018-12-01)

Research Progress of Macrophages in Development of Radiation Pneumonitis and Pulmonary Fibrosis
by: XU Yaping, et al.
Published: (2023-07-01)

Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
by: Jason Yongsheng Chan, et al.
Published: (2023-07-01)

Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis
by: Hiroyuki Ando, et al.
Published: (2021-10-01)

Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia
by: Ahmet Emre Eşkazan, et al.
Published: (2013-12-01)

Antibody-Drug Conjugate-Induced Pneumonitis: A Growing Threat
by: Kathy L. Chan, et al.
Published: (2025-04-01)

Case report: Checkpoint inhibitor pneumonitis with positive anti-melanoma differentiation-associated gene 5 antibodies in a patient with lung cancer
by: Siqi Pan, et al.
Published: (2024-01-01)

Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload
by: Aleksei Kondrashov, et al.
Published: (2023-08-01)

Imatinib-induced interstitial pneumonitis – a literature review and case report
by: Olga Hilda Orasan, et al.
Published: (2020-04-01)

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis
by: Chuzi S, et al.
Published: (2017-06-01)

Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease
by: Zhu Zeng, et al.
Published: (2022-12-01)

Pneumonitis as a complication of Immunotherapy of oncological diseases: difficulties in diagnosis and treatment
by: Yuliia S. Chizhova, et al.
Published: (2025-01-01)

Automation Radiomics in Predicting Radiation Pneumonitis (RP)
by: Sotiris Raptis, et al.
Published: (2023-07-01)

Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related pneumonitis triggered by immunotherapy followed by radiation: a case report
by: Yan Zhu, et al.
Published: (2024-11-01)

Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy
by: Rutger H. Stoffers, et al.
Published: (2025-02-01)

Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study
by: Huixia Li, et al.
Published: (2023-04-01)

A rare cause of pneumothorax: Diesel aspiration pneumonitis
by: Ajay K Verma, et al.
Published: (2018-01-01)

Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
by: Zhang A, et al.
Published: (2022-08-01)

Current management in hypersensitivity pneumonitis
by: Sara Salvador, et al.
Published: (2025-07-01)

Predictive value of machine learning for radiation pneumonitis and checkpoint inhibitor pneumonitis in lung cancer patients: a systematic review and meta-analysis
by: Shenghan Wang, et al.
Published: (2025-07-01)

Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report
by: Hong Li, et al.
Published: (2017-02-01)

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
by: Okuda R, et al.
Published: (2023-05-01)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
by: Xiaotong Lu, et al.
Published: (2022-06-01)

Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)

Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xiaoqing Zhou, et al.
Published: (2025-05-01)

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis
by: Ayodeji Adegunsoye, et al.
Published: (2017-10-01)